جست‌وجوی استاد و پژوهشگر

Melissa Mannersمشاهده پروفایل

استادیار

• Neuroscience
• Molecular Neuroscience
• Stress Neurobiology
• +۳ مورد دیگر

Melissa Manners, Ph.D., serves as Assistant Professor in the Department of Biological & Biomedical Sciences at Rowan University's College of Science & Mathematics, with additional teaching appointments at St. Joseph's University in Neuroscience graduate programs. Education: BA in Biology (Minor in Psychology), Rutgers University (2007) PhD in Pharmacology and Physiology, Drexel University College of Medicine (2016) Postdoctoral Fellowship, University of Pennsylvania (2016-2019) Research Focus: Dr. Manners investigates molecular mechanisms underlying chronic stress behavioral effects through neuroscience , molecular biology , and bioinformatics approaches. Her work examines gene expression alterations in disease states, drug treatment responses, and stress-induced neuroinflammation, with emphasis on sex differences and transgenerational effects. Key areas include: Stress neurobiology and resilience mechanisms Neuropharmacology of depression and opioids Molecular pathways in neurological disorders Epigenetic regulation in pain and stress Publication Trends: Recent work (2022-2025) reveals strong focus on sex-specific stress responses, gut microbiome-opioid interactions, and neuroinflammatory mechanisms using rodent models. Her research bridges molecular neuroscience with translational applications for depression and addiction treatment. Scientific Awards: No awards or fellowships were documented in source materials. Mentorship: Dr. Manners actively trains undergraduate and graduate students, evidenced by co-authorships with Elias, A.Y. Zhang, A.G. White, M.J.Pyle, J.K. Brynildsen, M. Schechter, X Liu, D.Eacret, and N.L. Yohn. She teaches core neuroscience courses including Cellular & Molecular Neuroscience, Neurobiology of Stress, and Brain Behavior and Disease across both institutions. Research Infrastructure: Source materials did not specify laboratory facilities or research team compositions.

• Dentistry
• Microbiology
• Natural Sciences
• +۵ مورد دیگر

Prof. Tanju Kadir is a distinguished academic at Marmara University, Faculty of Dentistry , where he has served as Professor since 2007. He holds the Head of Department position in the Department of Basic Medical Sciences and contributes to infection control as Chair of the Infection Control Committee. His career spans roles from Research Assistant (1988–1995) to Lecturer (1995–1996) and Assistant/Associate Professor (1996–2007). His research focuses on oral microbiology , particularly Candida albicans virulence, antimicrobial agents , and periodontal therapy . He has extensively studied Er:YAG laser applications , probiotics , and denture-associated biofilms . His recent work explores IoT-based infection control in dental clinics and sub-therapeutic antiseptics in microbial resistance. Prof. Kadir has supervised 7 theses and co-authored over 93 WoS-indexed publications , including 2025 studies on hexetidine-induced virulence gene expression and 2023 trials on probiotic adjuncts. He contributes to academic governance as a Senate Member (2021–2024) and participates in peer review for journals like BMC Oral Health and Probiotics and Antimicrobial Proteins . His editorial roles and book chapters solidify his influence in oral immunology and microbiome research .

Cristina Espinosa-Diezمشاهده پروفایل

استادیار

• Molecular Biology
• Epigenetics
• Vascular Biology
• +۵ مورد دیگر

Cristina Espinosa-Diez, PhD is an Assistant Professor of Molecular Medicine and Genetics and of Physiology at Wayne State University's School of Medicine in Detroit, Michigan. Her research focuses on understanding how cancer therapies shape the epigenetic landscape of vascular cells, potentially giving rise to long-term vascular complications through non-coding RNA mechanisms. Education PhD in Molecular Biology and Biomedicine from University Complutense, Madrid, Spain (2015) Postdoctoral researcher at Oregon Health and Science University (2015-2019) Postdoctoral fellow at University of Pittsburgh's Vascular Medicine Institute (2019-2023) Dr. Espinosa-Diez leads a non-coding-RNA laboratory investigating the response of long-non-coding RNAs to different anti-cancer agents and their role in vascular remodeling during disease progression. Her work integrates molecular biology, epigenetics, and vascular biology to understand how cancer treatments impact vascular health, with particular focus on microRNAs and their regulatory functions in endothelial and smooth muscle cells. Her research spans from basic mechanisms of epigenetic regulation to translational applications in cancer therapy complications. Analysis of her recent publications reveals a strong focus on non-coding RNA regulation in vascular biology, particularly examining how microRNAs and long non-coding RNAs influence smooth muscle cell phenotype, endothelial function, and vascular responses to stressors like radiation and metabolic syndrome. Her work demonstrates how epigenetic modifications, particularly histone methylation and non-coding RNA expression, govern vascular cell identity and function in both health and disease contexts. Scientific Awards American Heart Career Development Award Dr. Espinosa-Diez established her independent research program at Wayne State University in October 2023 after completing her postdoctoral training. Her laboratory investigates the intersection of cancer therapy, epigenetics, and vascular biology, with particular emphasis on understanding how treatments like radiation impact vascular cells through non-coding RNA mechanisms. She maintains active collaborations with researchers at multiple institutions and has developed a productive publication record spanning basic molecular mechanisms to potential clinical implications. Though currently not accepting new graduate students for 2025/2026, she has previously mentored students and postdoctoral researchers in her field. The Espinosa-Diez Lab functions as an interdisciplinary research team employing molecular, cellular, and epigenetic approaches to understand vascular complications associated with cancer treatments. The laboratory investigates how non-coding RNAs mediate the vascular side effects of cancer therapies, with potential implications for developing strategies to protect vascular health during oncological treatment.

• Proteomics
• Metabolomics
• Plant-Microbe Interactions
• +۳ مورد دیگر

Prof. Dr. Karsten Niehaus serves as Head of the Proteome and Metabolome Research Group at the Center for Biotechnology (CeBiTec) and Faculty of Biology, University of Bielefeld. His research focuses on proteomics and metabolomics applications in plant-microbe interactions, bacterial stress responses, and disease model systems. His laboratory employs advanced mass spectrometry imaging and cell phenotyping technologies to investigate molecular responses in crops like sugar beet and grapevines under abiotic stress conditions, as well as in cancer models where differentiation therapy impacts tumor malignancy. The group also explores microbial biotechnology through Xanthomonas campestris studies on xanthan production and stress adaptation. Selected publications highlight innovations in 3D microfluidics for biomarker detection and bioinformatics platforms like MetHoS for metabolomics data analysis. His work appears in journals covering Frontiers in Plant Science , Scientific Reports , and Journal of Experimental Botany . Contact: kniehaus@cebitec.uni-bielefeld.de | Office: UHG W7-117

Henri Tiedgeمشاهده پروفایل

استاد

• RNA Biology
• Neurobiology
• Translational Regulation
• +۵ مورد دیگر

Henri Tiedge, PhD , is a Professor at the Department of Physiology and Pharmacology within SUNY Downstate Medical Center . His research focuses on regulatory brain cytoplasmic (BC) RNAs , particularly their role in translational control mechanisms at neuronal synapses and their implications in neurological disorders and tumor biology . Institutional Affiliation: SUNY Downstate Medical Center (College of Medicine, Physiology and Pharmacology) Academic Rank: Professor Research Domains: RNA Biology, Synaptic Plasticity, Neurodegeneration, Oncology Dr. Tiedge investigates how BC1 and BC200 RNAs regulate local protein synthesis in dendrites through interactions with eukaryotic initiation factors (eIF4A/B) . His work demonstrates that BC RNA dysregulation leads to neuronal hyperexcitability , epileptogenesis , and cognitive dysfunction , with therapeutic applications in neuropsychiatric lupus using RNA decoys. He also explores BC RNA expression in germ cells and tumors , aiming to develop diagnostic/prognostic tools for cancer. Key publications include studies on RNA transport via hnRNP A2 and Purα , autoantibody-induced RNA displacement , and cross-talk between BC RNAs and FMRP in fragile X syndrome. His work has been supported by NIH grants NS046769 and DA026110 .

Jonas L. Juulمشاهده پروفایل

استادیار

• Network Science
• Social Networks
• Epidemiology
• +۵ مورد دیگر

Jonas L. Juul is an Assistant Professor in the Computer Science Department at the IT University of Copenhagen . With a background in network science and complex systems, he employs statistical methods, mathematical modeling, and computer simulations to study social networks, spreading processes, and human behavior. Focus areas include: information diffusion in social networks Disease spread mitigation in human populations Interdisciplinary collaboration with medical doctors, economists, and computer scientists Recent research highlights include improving statistical models for pandemic forecasting through the InForM project funded by the Novo Nordisk Foundation , and groundbreaking work on contact tracing optimization and information cascade dynamics. Notable recognitions: 2025 H.C. Ørsted Research Talent Prize 2024 Novo Nordisk Foundation Data Science Emerging Investigator Grant 2025 Young Academy membership He has contributed to mathematical modeling efforts during Denmark's COVID-19 reopening in 2020 and maintains active collaborations with institutions including Cornell University , Technical University of Denmark , and Niels Bohr Institute .

Benjamin Ortizمشاهده پروفایل

استاد

• Immunology
• T cell biology
• Gene regulation
• +۴ مورد دیگر

Benjamin Ortiz is a Professor of Biological Sciences and the Chair of the Department of Biological Sciences at Hunter College, part of the City University of New York (CUNY) system. He is affiliated with the School of Arts and Sciences at Hunter College. His educational background includes: B.A. from Hunter College (1990) Ph.D. from Stanford University (1996) Postdoctoral training at the University of California, Berkeley (1996-2000) Dr. Ortiz's research focuses on the molecular mechanisms of T cell development, particularly gene regulation during this process. His laboratory investigates the gene regulatory mechanisms that execute the T cell genetic program, with a specific focus on the regulation of the T cell receptor alpha chain (TCRa) locus and its locus control region (LCR). His work combines in vivo transgenic mouse models with in vitro T cell development systems using embryonic stem cells. A key aspect of his research examines how the TCRa LCR provides predictable gene expression patterns and insulation from genomic position effects. His research has significant implications for understanding basic immunological processes and for developing gene therapy applications targeting cancer and viral diseases like HIV. Dr. Ortiz's laboratory has developed important reagents and technologies that have enabled collaborations with other research groups investigating T cell development and function. His work bridges fundamental molecular immunology with potential translational applications in cancer immunotherapy and treatment of viral diseases affecting T cells. His scientific contributions have been recognized through numerous publications in prestigious journals including PLoS ONE, Journal of Immunology, Journal of Immunological Methods, and Journal of Biological Chemistry. Dr. Ortiz maintains an active research laboratory, the Ortiz Lab, which continues to investigate the molecular mechanisms of T cell development and gene regulation.

Russell Carrمشاهده پروفایل

استاد

• Toxicology
• Neurotoxicology
• Environmental Health
• +۳ مورد دیگر

Russell Carr , PhD, is a Professor at Mississippi State University's College of Veterinary Medicine. Holding a PhD in Animal Physiology (MSU, 1994) and MS in Biological Sciences (MSU, 1990), he focuses on neurotoxicology, pesticide mechanisms, and endocannabinoid system interactions. His career spans 30+ years studying organophosphate effects on neurotransmitter systems across developmental stages. Key Research Areas: Organophosphate pesticide neurotoxicity Endocannabinoid system disruption Developmental neurochemical impacts Cross-species enzyme inhibition Recent Publications (2023-2021) reveal trends in nanochannel CBD delivery systems, chlorpyrifos-induced proteomic changes in amygdala, and multi-omics approaches to pesticide-immune interactions. Earlier works establish foundational knowledge on cholinesterase inhibition kinetics and age-dependent toxicity profiles. Notable Contributions: Elucidated mechanisms of endocannabinoid enzyme inhibition by pesticides, demonstrated neurochemical impacts of low-dose exposures, and developed comparative models across species (rodents, fish).

Jenny Mortonمشاهده پروفایل

استاد

• Neurobiology
• Huntington's Disease Research
• Sleep Disorders
• +۳ مورد دیگر

Professor Jenny Morton is a leading neurobiologist at the University of Cambridge , Department of Physiology, Development and Neuroscience. Her research focuses on Huntington's disease using sheep and mouse models , investigating neurodegeneration , circadian rhythm disruption , and cognitive impairments . She serves as Director of Studies in Medicine and Veterinary Medicine at Newnham College. Professor of Neurobiology (Cambridge, 2018) Director of Studies, Newnham College Her lab develops translational animal models to study disease progression through neurophysiological recordings , EEG analysis , and magnetic resonance imaging . Recent work includes executive function assessment in sheep and pharmacological interventions for neurodegenerative symptoms. Key publications reveal trends in sleep disorder research , neural oscillation abnormalities , and environmental enrichment effects on Huntington's disease progression. The lab maintains a Cambridge MRI database for animal models and explores biomarker development through metabolic profiling.

Eran Halperinمشاهده پروفایل

استاد

• Computational Biology
• Genomics
• Machine Learning in Medicine
• +۴ مورد دیگر

Dr. Eran Halperin is a Professor at the University of California, Los Angeles, affiliated with the School of Engineering (Computer Science Department) and the School of Medicine (Human Genetics, Computational Medicine, Anesthesiology). His research bridges computational biology, genomics, and machine learning, with a focus on developing statistical methods to analyze big medical data for disease prediction and treatment. Developed open-source software tools like FEAST, ReFACTor, and Bisque Recipients of prestigious awards including Rothschild Fellowship and ISCB Fellow (2021) Research Interests: Computational Genomics: Applying machine learning to genomic data (methylation, RNA expression) for disease understanding. Machine Learning in Medicine: Creating deep learning architectures for ophthalmology, anesthesiology, and acute care applications. Medical Data Science: Integrating electronic health records with genomic datasets for predictive modeling. Scientific Recognition: Rothschild Fellowship Technion-Juludan Research Prize Krill Prize in Science Elected ISCB Fellow (2021) Dr. Halperin's lab collaborates across disciplines, utilizing software platforms such as GLINT (methylation analysis) and MTV-LMM (microbiome prediction). His work has received funding from NIH, NSF, and international foundations.

Kimia Witteمشاهده پروفایل

مدرس

• Stem Cell Engineering
• Biomaterials
• Tissue Engineering
• +۴ مورد دیگر

Dr. Kimia Witte is a Lecturer in Biomedical Engineering at the University of Strathclyde, UK, actively accepting PhD students. Her research focuses on innovative biomedical engineering approaches including stem cell manipulation using physical stimuli, biomaterial development for tissue regeneration, and diagnostic tool design. She specializes in creating bioinstructive environments for controlling cell behavior and developing novel biomaterial platforms. Research Focus Witte's core research integrates: Stem cell engineering using acoustic/physical stimulation Development of smart biomaterials for tissue regeneration Microfluidic platforms for diagnostic applications Mechanobiology approaches for clinical diagnostics Her work bridges fundamental biomaterial science with clinical applications in regenerative medicine and diagnostic technologies. Research Trends Analysis of her 12 most recent publications reveals: Strong focus on stem cell-microenvironment interactions Increasing emphasis on translationally-oriented research Development of novel diagnostic platforms Interdisciplinary approaches combining engineering, biology and materials science Progressive refinement of biomaterial systems Awards and Recognition Witte has received recognition for her scientific contributions including 1 prize (specific award unnamed in available data). Her publications show significant impact with multiple articles receiving 20+ citations. Academic Activities Maintains active research program with 18 projects and 3 datasets. Contributes to academic community through peer-reviewed publications and conference presentations. Collaborates with researchers across materials science, cell biology and clinical medicine disciplines.

Rafet Al-Tobaseiمشاهده پروفایل

دانشیار

• Bioinformatics
• Aquaculture Genetics
• RNA Sequencing
• +۵ مورد دیگر

Dr. Rafet Al-Tobasei serves as an Associate Professor in the Department of Computer Science at Middle Tennessee State University (MTSU), where he applies computational methodologies to solve complex biological problems in aquaculture species. His research bridges computer science and genomics to address critical challenges in fisheries science and genetic improvement programs. His academic credentials include: Ph.D. in Computer Science, Middle Tennessee State University (2017) M.A. in Computer Science, Middle Tennessee State University (2011) M.S. in Computer Science, Middle Tennessee State University (2011) B.S. in Computer Science, Tennessee State University (2007) Dr. Al-Tobasei's research program focuses on developing and implementing bioinformatics tools for aquaculture genomics, with particular emphasis on rainbow trout and Nile tilapia. His expertise spans RNA sequencing analysis, Genome-Wide Association Studies (GWAS), Single Nucleotide Polymorphism (SNP) discovery, Long non-coding RNA (lncRNA) characterization, DNA methylation profiling, and Chromatin Immunoprecipitation Sequencing (ChIP-Seq) data interpretation. He investigates molecular mechanisms underlying economically important traits including muscle growth, fillet quality, disease resistance, and stress response. Analysis of his publication record reveals consistent thematic progression in aquaculture genomics: early work established foundational genomic resources for rainbow trout, followed by sophisticated GWAS applications for trait mapping, and recent integration of multi-omics approaches (transcriptomics, epigenomics, and lipidomics). His research increasingly emphasizes practical breeding applications, with significant contributions to genomic selection methodologies using reduced-density SNP panels and advanced statistical models. While specific awards and grants aren't documented in the source material, his extensive publication record in high-impact journals like BMC Genomics and Scientific Reports demonstrates substantial scholarly impact. His collaborative network spans multiple institutions and includes frequent co-authorship with leading aquaculture geneticists, indicating active participation in the research community and likely involvement in mentoring graduate students through research projects.

Diego di Bernardoمشاهده پروفایل

استاد

• Genomic Medicine
• Systems and Synthetic Biology
• Biomedical Engineering
• +۴ مورد دیگر

Diego di Bernardo is a Full Professor of Biomedical Engineering at the University of Naples Federico II and Principal Investigator at TIGEM, serving as Coordinator of the Genomic Medicine Program and Head of the Bioinformatics Core. His work bridges engineering and biological sciences to advance disease understanding and therapeutic development. His educational background includes a Laurea cum laude in Electronic Engineering from the University of Naples Federico II (1997) and a PhD in Medical Physics from the University of Newcastle School of Medicine (2001), funded by a European Commission Marie Curie Fellowship. Postdoctoral training followed at the Wellcome Trust Sanger Center and Boston University. Di Bernardo's research integrates Biomedical Engineering, Control Engineering, and Molecular Biology to pioneer Biomolecular Control. His lab develops microfluidics platforms for real-time cellular analysis and computational approaches for gene network reverse engineering and drug repositioning. Current work focuses on single-cell transcriptomics to combat drug resistance in cancer and engineer stress-response pathways for bioproduction optimization. His publication record demonstrates consistent innovation in computational biology, with recent work emphasizing pan-cancer transcriptomics, microfluidics-based cell control, and bioinformatics tool development for pathway analysis. The research trajectory shows increasing integration of engineering principles with genomic medicine. Scientific recognition includes: Marie Curie Fellowship He advises PhD students including Clarissa Poles and Virginia Fusco, leading a multidisciplinary team of postdocs and bioinformaticians. Major funding sources include Telethon, AIRC, Italian Ministries, HFSP, and EU programs such as Re-MEND (2023-2027) for mental health resilience and iPC (2019-2023) for pediatric cures. His TIGEM laboratory operates cutting-edge microfluidics and bioinformatics facilities to engineer living systems, with current projects targeting super-producer cell lines for biological drugs and viral vectors while reducing production costs through stress-response re-engineering.

• Hemostasis
• Thrombosis
• Stem Cell Research
• +۳ مورد دیگر

Ulrich Klostermeier is a researcher at the Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf (UKE). His scientific work spans hemostasis, thrombosis research, and molecular mechanisms of coagulation disorders. Hematology Clinical Chemistry Stem Cell Research Translational Medicine His research focuses on thrombophilia , venous thromboembolism , and genetic regulation in both pediatric and adult populations. Key projects include investigations into protein C/S deficiencies , NOD2 interactions , and hemostatic biomarkers . Recent publications demonstrate expertise in translational thrombosis research , with significant contributions to understanding prothrombotic polymorphisms and stem cell applications in cardiac regeneration. Collaborative work includes international cohort studies and multicenter clinical research. Methodologically, he employs transcriptional profiling , mutation analysis , and animal models for studying blood coagulation dynamics. His scientific work has been published in journals covering hematology, molecular biology, and clinical chemistry. Key research trends: Thrombosis risk stratification Genetic basis of coagulation disorders Comparative pediatric/adult hemostasis Translational approaches to cardiac repair Computational transcriptional analysis Developmental biology applications

Eva Henriette Gottweinمشاهده پروفایل

دانشیار

• MicroRNA
• Viral Oncology
• Virology
• +۷ مورد دیگر

Eva Henriette Gottwein is an Associate Professor in the Department of Microbiology-Immunology at Northwestern University's Feinberg School of Medicine. Her research is primarily focused on Kaposi's sarcoma-associated herpesvirus (KSHV) and its role in viral oncogenesis, particularly as it relates to cancers that develop in immunocompromised individuals. She maintains active affiliations with the Robert H. Lurie Comprehensive Cancer Center and the Simpson Querrey Institute for Epigenetics, which provide critical infrastructure and collaborative opportunities for her work. Dr. Gottwein earned her PhD from Heidelberg University in Germany in 2005. Her laboratory investigates the molecular mechanisms by which KSHV causes cancer, with particular emphasis on viral microRNAs and their role in host cell manipulation. Her research spans both KSHV-infected B cells (which can lead to primary effusion lymphoma) and endothelial cells (which drive Kaposi's sarcoma). Her research interests center on understanding how KSHV-encoded microRNAs contribute to viral pathogenesis and oncogenesis. Specifically, her lab investigates KSHV-mediated B cell transformation in primary effusion lymphoma, mechanisms of KSHV-mediated endothelial cell deregulation, identification of drug targets for KSHV-associated cancers, and the targets and functions of KSHV-encoded microRNAs. Her team has pioneered the use of CRISPR screening technology to identify essential genes in primary effusion lymphoma, revealing novel therapeutic targets including IRF4, cyclin D2, MDM2, MCL1, and cellular FLIP. Analysis of Dr. Gottwein's recent publications reveals a consistent focus on viral oncogenesis with particular emphasis on molecular mechanisms of KSHV infection. Her work bridges virology, cancer biology, and molecular genetics, with increasing application of cutting-edge genomic technologies like CRISPR screens. Her research demonstrates a clear trajectory from basic molecular mechanisms toward identification of therapeutic targets for KSHV-associated malignancies. Dr. Gottwein actively mentors several graduate students in the Medical Biochemistry and Pharmacology (MBP) and Developmental Genetics and Molecular Biology (DGP) programs, including Shreya Jambardi, Neil Kuehnle, and Jesus Ortega. Her laboratory maintains active collaborations with researchers at institutions including the Heinrich Pette Institute in Hamburg, reflecting the international nature of virology research. While specific grant information isn't detailed in the provided materials, her extensive publication record in high-impact journals suggests successful funding from major research agencies. The Eva Gottwein Laboratory maintains a strong presence within Northwestern's research ecosystem, with particular connections to cancer research centers. Her team works at the intersection of virology and oncology, focusing on mechanistic studies with translational potential. The lab's work on CRISPR screens has positioned them at the forefront of identifying novel therapeutic targets for primary effusion lymphoma, an area with significant unmet clinical need.